H3B-6527 T7738
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma, with antineoplastic activity.
CAS nr:
1702259-66-2
Purity:
98%
Molecular Weight:
629,53
SMILES:
C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1
Formula:
C29H34Cl2N8O4
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis
Target:
FGFR,FGFR
